-
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)
(PAR-19-352)
National Cancer Institute
Application Receipt Date(s): October 17, 2019; then Standard dates apply.
The first standard due date for this FOA is February 5, 2020.
-
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)
(PAR-19-353)
National Cancer Institute
Application Receipt Date(s): October 21, 2019; May 27, 2020; October 21, 2020; May 27, 2021; October 21, 2021; May 27, 2022
, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)
(PAR-19-354)
National Cancer Institute
Application Receipt Date(s): October 21, 2019; May 27, 2020; October 21, 2020; May 27, 2021; October 21, 2021; May 27, 2022
-
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)
(PAR-19-355)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is October 16, 2019
-
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
(PAR-19-356)
National Cancer Institute
Application Receipt Date(s): October 18, 2019; February 20, 2020, June 19, 2020; October 20, 2020; February 19, 2021; June 21, 2021; October 20, 2021; February 22, 2022; June 21, 2022
-
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)
(PAR-19-358)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is October 16, 2019
-
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)
(PAR-19-359)
National Cancer Institute
Application Receipt Date(s): Standard dates apply.
The first standard due date for this FOA is October 16, 2019.
-
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
(PAR-19-360)
National Cancer Institute
Application Receipt Date(s): October 17, 2019; then Standard dates apply.
The first standard due date for this FOA is February 5, 2020.
-
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)
(PAR-19-361)
National Cancer Institute
Application Receipt Date(s): November 12, 2019; March 11, 2020; November 12, 2020; March 11, 2021; November 12, 2021; March 11, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Food as Medicine: Food Insecurity and HIV-related Comorbidities, Coinfections, and Complications within the Mission of the NIDDK (R01 Clinical Trial Optional)
(RFA-DK-19-019)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)
(RFA-NS-19-038)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): October 22, 2019
No late applications will be accepted for this Funding Opportunity Announcement.
-
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (U24 - Clinical Trial Required -Infrastructure)
(RFA-OD-19-025)
National Institutes of Health
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): December 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Clinical Sites for the ECHO IDeA States Pediatric Clinical Trials Network - 2 (UG1 Clinical Trial Required)
(RFA-OD-19-026)
National Institutes of Health
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): December 2, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional)
(RFA-RM-19-013)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): December 27, 2019